News by Subject
News by Disease
News by Date
Post Your News
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
US & Canada
Post an Event
News | News By Subject | News by Disease |
News By Date | Search News
Aesica Recruits New East Coast Business Development Manager to Spearhead Growth in Contract Manufacturing Market Share Across the U.S. Region
10/29/2013 8:52:13 AM
29 October 2013 - USA: Aesica, the global contract development and manufacturing organisation (CDMO), has today announced the appointment of Baali Muganga to the role of East Coast U.S. Business Development Manager. Central to the new role is responsibility for expanding the share of the company’s east coast North American contract development and manufacturing market in pharmaceuticals.
In terms of US focused expertise, Baali brings in excess of five years new business experience gained across the life sciences industry. Key roles have included business development, commercial operations and clinical and bioinformatics research. Recently, she served in the role of Associate Alliance Manager with Reata Pharmaceuticals, a Dallas-based biopharmaceutical company. Prior to this, she worked at AstraZeneca and the Children’s Hospital of Philadelphia. She received a B.A. degree in Biological Basis of Behavior from the University of Pennsylvania.
Specifically, Baali Muganga will be responsible for targeting small to medium sized life science and pharmaceutical companies requiring product development and manufacturing support. As a two pronged strategic approach, Baali will have responsibility for expanding business from existing customers, as well as securing new client wins for the Group.
Aesica is also pleased to announce the engagement of Julius Lodato as Aesica LLC’s Director of Finance and Administration in order to support the growing US office. Julius is a highly experienced CPA with a Masters in taxation. Previous roles include a tenure at DSM Pharma. Emma Mickley stated: “We are very pleased that Julius has joined our team. His understanding of the contract pharmaceutical and manufacturing market will be pivotal in the continued growth of the Aesica’s operations in the US and North America”.
Commenting on Baali Muganga’s appointment, Emma Mickley, VP, Corporate Business Development at Aesica commented: “We are delighted to have Baali Muganga join the Aesica sales force. We look forward to leveraging her expertise gained through working for companies like Reata Pharmaceuticals and AstraZeneca, to help expand our presence across North America.”
She continued: “To date Aesica has successfully established many key partnerships in North America, and the intended acquisition of a development and manufacturing centre in this region will enable us to provide even greater levels of service to existing and new clients.”
“We have a strong international track record for service excellence, with an individualised and highly flexible service model, and an extensive range of services across API manufacture, formulation development and formulated products. As such we look forward to bringing significantly more of what we offer to the US market as we continue to build our USA footprint.”
Aesica supplies contract development and contract manufacturing services for Formulated Products and Active Pharmaceutical Ingredients to a host of the world’s leading pharmaceutical companies and emerging biotechnology organisations.
The uniqueness of Aesica lies in its flexible and bespoke approach to service delivery, coupled with its ability to develop products from the initial clinical stage through to final commercial supply. It is this all-encompassing offering combined with its dedication to exceptional standards of service that truly sets Aesica apart from its counterparts.
- Aesica is one of the UK’s fastest growing companies and over the last five years has more than trebled its turnover.
- The company currently employs approximately 1,300 people.
- In addition to its headquarters in Newcastle upon Tyne, UK, Aesica has development and manufacturing sites across Europe including Cramlington, Nottingham and Queenborough in the UK, as well as sites in Monheim and Zwickau in Germany and Pianezza in Italy. It also has sales representation in San Diego and Shanghai.
- The vision of Aesica is to become the number one supplier of APIs and formulated products to the pharmaceutical industry.
For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: +44 (0) 20 7203 6740/6745 or e-mail; email@example.com.
Help employers find you! Check out all the jobs and post your resume.